Praxis Dr. med. Abdou Zarzour
- Address
- lock Available on a paid plan
Praxis Dr. med. Abdou Zarzour - Dermatological Clinical Research Center
Praxis Dr. med. Abdou Zarzour is a specialized dermatological research center with extensive expertise in conducting clinical trials for a wide range of inflammatory and chronic skin conditions. The practice demonstrates particular proficiency in evaluating topical therapeutic agents, including corticosteroids, biologics, and innovative regenerative medicine approaches for dermatological disorders.
- Chronic inflammatory skin conditions including psoriasis, atopic dermatitis, and rosacea
- Wound healing research, particularly chronic venous ulcers with stem cell therapies
- Acne vulgaris and actinic keratosis treatment studies
- Autoimmune skin disorders including vitiligo
The center has established significant research experience in comparative efficacy studies of topical formulations, including generic versus originator products, and has contributed to advancing novel therapeutic approaches such as allogeneic stem cell applications for therapy-resistant chronic wounds. The practice's research portfolio spans from common dermatological conditions like papulopustular acne to more complex conditions requiring systemic therapy, demonstrating comprehensive capabilities in both Phase 2 and Phase 3 clinical trial conduct with rigorous safety and efficacy assessments.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Dermapharm AG3active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Dermapharm AG5trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Praxis Dr. med. Abdou Zarzour
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Adaptive Phase 3 Study to Evaluate the Efficacy and Safety of Sinecatechins (Defined Extract of Green Tea Leaves) Ointment in Adult Patients with Actinic Keratosis of the Scalp and the Face. | Aresus Pharma GmbH | Phase III | Recruiting | Sep 2024 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells | 2 | Unknown | 2021-08-18 | 2025-01-16 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.